Abstract
Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.
Similar content being viewed by others
References
R.A. DeLellis, R.V. Lloyd, P.U. Heitz, Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors, ed. by R.A. DeLellis, R.V. Lloyd, et al. (IARC Press, Lyon, 2004), pp. 64–66
S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)
Y. Ito, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma, A. Miyauchi, An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003)
E. Baudin, J.P. Travagli, J. Ropers, F. Mancusi, G. Bruno-Bossio, B. Caillou, A.F. Cailleux, J.D. Lumbroso, C. Parmentier, M. Schlumberger, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83, 553–559 (1998)
E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M.R. Ambrosio, L. Busutti, E.N. Pearce, L.E. Braverman, E.C. Degli Uberti, Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrinol. Metab. 91, 2171–2178 (2006)
J.Y. Kwak, E.-K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.-H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16, 1348–1355 (2009)
I.D. Hay, E.J. Bergstralh, J.R. Goelner, J.R. Ebersold, C.S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114, 1050–1058 (1993)
S.M. Chow, S.C.K. Law, J.K. Chan, S.K. Au, S. Yau, W.H. Lau, Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98, 31–40 (2003)
S. Noguchi, H. Yamashita, S. Uchino, S. Watanabe, Papillary microcarcinoma. World. J. Surg. 32, 747–753 (2008)
I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112, 1139–1146 (1992)
N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)
K.D. Lin, J.D. Lin, M.J. Huang, H.S. Huang, L.B. Jeng, T.C. Chao, Y.S. Ho, Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg. 82, 378–381 (1997)
Y. Ito, T. Jikuzono, T. Higashiyama, S. Asahi, C. Tomoda, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. 30, 1821–1828 (2006)
C. Cappelli, M. Castellano, M. Braga, E. Gandossi, I. Pirola, E. De Martino, B. Agosti, E.A. Rosei, Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J. Surg. Oncol. 95, 555–560 (2007)
N. Arora, H.K. Turbedian, M.A. Kato, T.A. Moo, R. Zarnegar, T.J. Fahey 3rd, Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 5, 473–477 (2009)
J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS. Med. 4, e297 (2007). doi:10.1371/journal.pmed
A. Pisanu, I. Reccia, O. Nardello, A. Uccheddu, Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J. Surg. 33, 460–468 (2009)
J. Schonberger, J. Marienhagen, A. Agha, S. Rozeboom, E. Bachmeier, H. Schlitt, C. Eilles, Papillary microcarcinoma and papillary cancer of the thyroid B1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46, 115–120 (2007)
S. Grodski, T. Brown, S. Sidhu, A. Gill, B. Robinson, D. Learoyd, M. Sywak, T. Reeve, L. Delbridge, Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144, 1038–1043 (2008)
E.L. Mazzaferri, J. Sipos, Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and pre-operative neck ultrasonography to define the extent of tumor invasion? Thyroid 18, 597–602 (2008)
M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, P. Bernante, D. Casara, G. Pennelli, D. Rubello, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl. Med. Commun. 25, 547–552 (2004)
I. Sugitani, Y. Fujimoto, Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. 46, 209–216 (1999)
Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)
G. Lupoli, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri, A.R. Bianco, Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353, 637–639 (1999)
G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini, R. Valcavi, V. Barbieri, Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19, 707–716 (2009)
J.S. Choi, E.-K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.1007/s120120-014-0293-z
H.J. Shin, E.-K. Kim, H.J. Moon, J.H. Yoon, K.-H. Han, J.Y. Kwak, Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma? Endocrine (2013). doi:10.1007/s12020-013-0131-8
T.Y. Kim, S.J. Hong, M. Kim, W.G. Kim, G. Gong, J.S. Ryu, W.B. Kim, S.-C. Yun, Y.K. Shong, Prognostic parameters for recurrence of papillary thyroid microcarcinoma. B.M.C. Cancer 8, 296 (2008)
E.J. Kuo, P. Goffredo, J.A. Sosa, S.A. Roman, Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph node metastases: a population-level analysis. Thyroid 23, 1305–1311 (2013)
K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, J.M. Qu, The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 17, 3294–3300 (2010)
Acknowledgments
This study was supported by a Grant from the University of Cagliari, Italy (CAR 2012).
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pisanu, A., Saba, A., Podda, M. et al. Nodal metastasis and recurrence in papillary thyroid microcarcinoma. Endocrine 48, 575–581 (2015). https://doi.org/10.1007/s12020-014-0350-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0350-7